Light Exposure for Sleep and Circadian Rhythms
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn how the pupil responds to different light stimuli and how that relates to sleep and daily rhythms in healthy people of different ages. The main questions it aims to answer are: * Does the eye's pupil response to light stimuli differ by the sex and age of the participant? * Is the eye's pupil response to light stimuli related to each participant's sleep timing, their body clock timing, and their hormone responses to light. Participants will have a special eye exam and complete questionnaires before starting the study to see if they can participate. If they can participate, they will wear a special watch that monitors their activity and light levels for one week. Then they will live in a research room at the Mass General Hospital for 3 days/2 nights during which we will test their pupil response to light, their body clock timing, and their hormone responses to light.
Will I have to stop taking my current medications?
The trial requires that participants do not take prescription or non-prescription drugs that affect the pupil, sleep, melatonin, or circadian rhythms. If you are on such medications, you may need to stop taking them to participate.
What data supports the effectiveness of this treatment for sleep and circadian rhythm issues?
Research shows that light therapy can effectively improve sleep and mood by influencing circadian rhythms, which are the body's natural sleep-wake cycles. Studies have demonstrated that controlled light exposure can help treat sleep and mood disorders by aligning the body's internal clock with the day-night cycle, leading to better sleep quality and mood stability.12345
Is light exposure generally safe for humans?
How does the treatment 'Non-visual Light Input' differ from other treatments for sleep and circadian rhythm issues?
Non-visual Light Input is unique because it uses specific properties of light, such as intensity, duration, and wavelength, to influence sleep and wakefulness by affecting the body's internal clock and melatonin levels. Unlike traditional treatments that might involve medication, this approach leverages light exposure to naturally regulate sleep patterns and improve sleep quality.38111213
Research Team
Elizabeth Klerman, MD PhD
Principal Investigator
Mass. General Hospital
Eligibility Criteria
This trial is for healthy individuals aged 18-85 with a normal sleep schedule (bedtime between 10 pm and 1 am, wake time between 5:30 am and 8:30 am), vision correctable to at least 20/30, and no major medical issues.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Pre-study Monitoring
Participants wear a special watch that monitors their activity and light levels
In-hospital Testing
Participants live in a research room for 3 days/2 nights for testing pupil response, circadian timing, and hormone responses to light
Follow-up
Participants are monitored for any delayed responses or effects post-study
Treatment Details
Interventions
- Eye Exam
- Melatonin Suppression Test
- Non-visual Light Input
- Pupillometry
Find a Clinic Near You
Who Is Running the Clinical Trial?
Massachusetts General Hospital
Lead Sponsor